Compare DexCom, Inc. (DXCM) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs NextEra Energy, Inc. — how do they compare? DexCom, Inc. trades at $77.75 (market cap $28.06B), while NextEra Energy, Inc. trades at $89.21 (market cap $185.83B). The key difference: NextEra Energy, Inc. is far larger — about 6.6× DexCom, Inc.'s market cap, and NextEra Energy, Inc. pays a 2.8% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | NEE | |
|---|---|---|
Market Cap | $28.06B | $185.83B |
Sector | Health | Utilities |
52-Week High | $89.53 | $97.88 |
52-Week Low | $54.84 | $69.77 |
Enterprise Value | $27.03B | $288.23B |
Dividend Yield | — | 2.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
NextEra Energy (NEE) trades at $89.54, up 1.31% recently, with a bullish technical outlook supported by moving averages and ADX signals. The stock shows strong profitability with a 29.37% net margin and 15.58% ROE, though P/E of 22.61 and P/B of 3.37 indicate premium valuation. Recent news highlights a proposed merger with Dominion Energy, potentially expanding reach across high-growth states, while Q2 2026 earnings are anticipated on July 24, 2026.
NEE presents a favorable long-term outlook driven by clean energy demand and strategic growth initiatives, with a consensus price target of $103 offering 15% upside. Risks include regulatory hurdles from the Dominion merger, rising debt levels (debt-to-asset ratio up to 47.6% in 2025), and volatile cash flows, but analyst sentiment remains strongly bullish with 66.7% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
